Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Public ClinicalTrials.gov record NCT03046056. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy and Safety of Filgotinib in the Treatment of Small Bowel Crohn's Disease (SBCD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of filgotinib, when compared to placebo, in establishing clinical remission defined as Crohn's disease activity index (CDAI) \< 150, at Week 24 in participants with small bowel Crohn's disease (CD). Participants will have the option to enter a separate long-term extension study if they meet eligibility requirements.
Study identification
- NCT ID
- NCT03046056
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 11, 2017 (Actual)
- Primary completion
- Jul 20, 2020 (Actual)
- Completion
- Jul 20, 2020 (Actual)
- Last update posted
- Aug 23, 2021
2017 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Miami Crohn's and Colitis Center | Miami | Florida | 33136 | — |
| Center for lnterventional Endoscopy- Florida Hospital | Orlando | Florida | 32804 | — |
| University of South Florida South Tampa campus | Tampa | Florida | 33606 | — |
| Indiana University Health University Hospital | Indianapolis | Indiana | 46202 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Gastro Center of Maryland | Columbia | Maryland | 21045 | — |
| Meritus Center for Clinical Research | Hagerstown | Maryland | 21742 | — |
| Clinical Research Institute of Michigan | Chesterfield | Michigan | 48047 | — |
| Fargo Gastroenterology and Hepatology Clinic | Fargo | North Dakota | 58103 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| Gastroenterology Research of San Antonio | San Antonio | Texas | 78229 | — |
| TDDC San Marcos | San Marcos | Texas | 78666 | — |
| Texas Digestive Disease Consultants | Southlake | Texas | 76092 | — |
| McGuire DVAMC | Richmond | Virginia | 23249 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03046056, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2021 · Synced Oct 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03046056 live on ClinicalTrials.gov.